(MC) Moelis - Overview
Stock: M&A Advisory, Restructuring, Capital Markets, Strategic Advisory
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.03% |
| Yield on Cost 5y | 6.37% |
| Yield CAGR 5y | -8.75% |
| Payout Consistency | 88.7% |
| Payout Ratio | 87.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 35.2% |
| Relative Tail Risk | -4.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.07 |
| Alpha | -25.12 |
| Character TTM | |
|---|---|
| Beta | 1.449 |
| Beta Downside | 1.488 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.31% |
| CAGR/Max DD | 0.61 |
Description: MC Moelis January 09, 2026
Moelis & Company (NYSE: MC) is a global independent investment-banking advisory firm that provides M&A, recapitalization, restructuring, capital-markets, and strategic advisory services to a broad client set that includes public corporations, middle-market owners, financial sponsors, governments and sovereign wealth funds. Founded in 2007 and headquartered in New York, the firm operates across the Americas, Europe, the Middle East, Asia and Australia.
In FY 2023 the company generated approximately $2.0 billion in advisory-fee revenue, delivering a net income margin near 27 % and a return on equity (ROE) of roughly 23 %, reflecting its high-margin, low-leverage business model. Moelis’ deal pipeline is heavily weighted toward large-cap cross-border transactions, which historically account for about 55 % of total fee revenue.
Key sector drivers for Moelis include the health of global M&A activity (which is sensitive to corporate cash balances, interest-rate cycles, and regulatory clearance timelines) and the availability of distressed-asset opportunities that rise during periods of tightening credit conditions. A rising trend in private-equity-backed deals and sovereign-wealth-fund diversification also fuels demand for Moelis’ strategic advisory expertise.
For a deeper quantitative view of Moelis & Co.’s performance and valuation dynamics, you might explore the firm’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 233.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.34 > 0.02 and ΔFCF/TA 20.25 > 1.0 |
| NWC/Revenue: -16.43% < 20% (prev -15.86%; Δ -0.57% < -1%) |
| CFO/TA 0.36 > 3% & CFO 552.9m > Net Income 233.0m |
| Net Debt (267.7m) to EBITDA (284.6m): 0.94 < 3 |
| Current Ratio: 0.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.6m) vs 12m ago 2.42% < -2% |
| Gross Margin: 31.69% > 18% (prev 0.31%; Δ 3139 % > 0.5%) |
| Asset Turnover: 104.7% > 50% (prev 86.63%; Δ 18.12% > 0%) |
| Interest Coverage Ratio: -4.98 > 6 (EBITDA TTM 284.6m / Interest Expense TTM -54.8m) |
Altman Z'' -1.61
| A: -0.16 (Total Current Assets 381.7m - Total Current Liabilities 630.9m) / Total Assets 1.52b |
| B: -0.55 (Retained Earnings -836.7m / Total Assets 1.52b) |
| C: 0.19 (EBIT TTM 272.7m / Avg Total Assets 1.45b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 898.6m) |
| Altman-Z'' Score: -1.61 = D |
What is the price of MC shares?
Over the past week, the price has changed by +2.23%, over one month by -1.43%, over three months by +15.55% and over the past year by -2.87%.
Is MC a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 2
What are the forecasts/targets for the MC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 80.2 | 9.5% |
| Analysts Target Price | 80.2 | 9.5% |
| ValueRay Target Price | 84.4 | 15.2% |
MC Fundamental Data Overview February 07, 2026
P/E Forward = 20.3252
P/S = 3.6231
P/B = 9.8046
P/EG = 1.97
Revenue TTM = 1.52b USD
EBIT TTM = 272.7m USD
EBITDA TTM = 284.6m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 267.7m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 267.7m USD (using Total Debt 267.7m, CCE unavailable)
Enterprise Value = 5.58b USD (5.32b + Debt 267.7m - (null CCE))
Interest Coverage Ratio = -4.98 (Ebit TTM 272.7m / Interest Expense TTM -54.8m)
EV/FCF = 10.67x (Enterprise Value 5.58b / FCF TTM 523.4m)
FCF Yield = 9.37% (FCF TTM 523.4m / Enterprise Value 5.58b)
FCF Margin = 34.51% (FCF TTM 523.4m / Revenue TTM 1.52b)
Net Margin = 15.36% (Net Income TTM 233.0m / Revenue TTM 1.52b)
Gross Margin = 31.69% ((Revenue TTM 1.52b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 36.82% (prev 28.43%)
Tobins Q-Ratio = 3.68 (Enterprise Value 5.58b / Total Assets 1.52b)
Interest Expense / Debt = 0.69% (Interest Expense 1.85m / Debt 267.7m)
Taxrate = 28.23% (39.0m / 138.0m)
NOPAT = 195.7m (EBIT 272.7m * (1 - 28.23%))
Current Ratio = 0.61 (Total Current Assets 381.7m / Total Current Liabilities 630.9m)
Debt / Equity = 0.50 (Debt 267.7m / totalStockholderEquity, two quarters ago 535.0m)
Debt / EBITDA = 0.94 (Net Debt 267.7m / EBITDA 284.6m)
Debt / FCF = 0.51 (Net Debt 267.7m / FCF TTM 523.4m)
Total Stockholder Equity = 494.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.09% (Net Income 233.0m / Total Assets 1.52b)
RoE = 47.15% (Net Income TTM 233.0m / Total Stockholder Equity 494.3m)
RoCE = 30.76% (EBIT 272.7m / Capital Employed (Total Assets 1.52b - Current Liab 630.9m))
RoIC = 38.23% (NOPAT 195.7m / Invested Capital 511.8m)
WACC = 10.73% (E(5.32b)/V(5.58b) * Re(11.25%) + D(267.7m)/V(5.58b) * Rd(0.69%) * (1-Tc(0.28)))
Discount Rate = 11.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.51%
[DCF Debug] Terminal Value 72.35% ; FCFF base≈392.6m ; Y1≈470.0m ; Y5≈746.8m
Fair Price DCF = 106.4 (EV 8.14b - Net Debt 267.7m = Equity 7.87b / Shares 74.0m; r=10.73% [WACC]; 5y FCF grow 21.03% → 2.90% )
EPS Correlation: 31.76 | EPS CAGR: 4.74% | SUE: 1.38 | # QB: 1
Revenue Correlation: 68.22 | Revenue CAGR: 13.64% | SUE: 1.01 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.71 | Chg30d=-0.016 | Revisions Net=+4 | Analysts=11
EPS current Year (2026-12-31): EPS=3.48 | Chg30d=+0.145 | Revisions Net=+8 | Growth EPS=+16.2% | Growth Revenue=+17.6%
EPS next Year (2027-12-31): EPS=4.27 | Chg30d=+0.181 | Revisions Net=+8 | Growth EPS=+22.8% | Growth Revenue=+16.8%